A proof-of-concept clinical study examining the NRF2 activator sulforaphane against neutrophilic airway inflammation

Overview of attention for article published in Respiratory Research, July 2016

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (72nd percentile)
High Attention Score compared to outputs of the same age and source (82nd percentile)

Mentioned by

twitter: 4 X users
facebook: 1 Facebook page

wikipedia: 1 Wikipedia page

Citations

dimensions_citation: 40 Dimensions

Readers on

mendeley: 75 Mendeley

Summary X Facebook Wikipedia Dimensions citations

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 1,202 followers.

A proof-of-concept clinical study examining the NRF2 activator sulforaphane against neutrophilic airway inflammation. https://t.co/Z44UdTBmYr #brassica

29 Nov 2017

Reply Repost Favourite

#respiratoryresearch A proof-of-concept clinical study examining the NRF2 activator… https://t.co/zrb6pNiMjG

22 Jul 2016

Reply Repost Favourite

RT @CasgoConnection: A proof-of-concept clinical study examining the NRF2 activator sulforaphane against neutrophilic airway inflammation h…

22 Jul 2016

Reply Repost Favourite

A proof-of-concept clinical study examining the NRF2 activator sulforaphane against neutrophilic airway inflammation https://t.co/sqALOd8l1L

22 Jul 2016

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.